FOXO4-DRI is an innovative senolytic peptide designed to selectively target and eliminate senescent 'zombie' cells. As a D-retro-inverso analog of the FOXO4 protein segment, it disrupts the FOXO4-p53 interaction in senescent cells, freeing p53 to trigger apoptosis and clear dysfunctional cells.
Cellular Rejuvenation
Anti-aging peptides protect telomeres and activate cellular renewal.
Quickstart Highlights
- Dosage: 300-500mcg
- Frequency: Daily during dosing weeks
- Administration: Subcutaneous
- Cycle length: 2-6 weeks (intermittent)
Dosing Plan
| Weeks | Dose | Units |
|---|---|---|
| Week 1 (Days 1–7) | 300mcg | 9 units (0.09mL) |
| Week 2 (Days 8–14) | Off | No injection |
| Week 3 (Days 15–21) | 400mcg | 12 units (0.12mL) |
| Week 4 (Days 22–28) | Off | No injection |
How to mix
Add 3.0mL bacteriostatic water per 10mg vial → 3.33mg/mL concentration
- Draw 3.0mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label with date and refrigerate at 2–8°C, protected from light.
Syringe Math Reference
- 10mg vial with 3mL BAC water = 3.33 mg/mL
- 1 unit = 0.01mL ≈ 33.3mcg
- 300mcg = 9 units
- 400mcg = 12 units
- 500mcg = 15 units
What you'll need
FOXO4-DRI Vials (10mg)
- 1 cycle (2 weeks) 1 vial
- 2 cycles (4 weeks) 1 vial
- 3 cycles (6 weeks) 2 vials
Insulin Syringes (U-100)
- 1 cycle 7 syringes
- 2 cycles 14 syringes
- 3 cycles 21 syringes
Bacteriostatic Water (10mL)
- 3 cycles 1 bottle
Alcohol Swabs
- 3 cycles 1 × 100-count box
How This Works
FOXO4-DRI is a cell-penetrating peptide antagonist that targets the FOXO4-p53 interaction in senescent cells. In senescent cells, FOXO4 abnormally accumulates in the nucleus and binds to p53, preventing apoptosis. FOXO4-DRI displaces native FOXO4 from p53, freeing p53 to relocalize to mitochondria and initiate apoptosis specifically in senescent cells, while sparing healthy cells.
Mechanism of Action
How FOXO4-DRI Works in Your Body
Peptide Administered
Distributes to cells throughout the body
Cellular Protection
Activates telomerase and DNA repair pathways
Autophagy Triggered
Old, damaged cells are cleared and recycled
Rejuvenation
Collagen production increases, cells function younger
Benefits & Side Effects
Potential Benefits
- Selective clearance of senescent cells
- Improved physical fitness in preclinical models
- Restored organ function
- Reduced tissue fibrosis
- Enhanced hormonal balance
- Potential tissue rejuvenation
Potential Side Effects
- Generally well tolerated in animal studies
- Mild injection site reactions
- No overt adverse effects in preclinical research
- Limited human safety data
How to store it
- Lyophilized: Store at −20°C or below; −80°C ideal for long-term.
- Reconstituted: Refrigerate at 2–8°C; use within 28 days.
- Allow vials to reach room temperature before opening.
- Protect from light.
Good to know
- Senolytics work best with intermittent 'hit-and-run' dosing.
- 1 week on, 1 week off cycle structure.
- D-retro-inverso configuration provides protease resistance.
- Selectively targets senescent cells while sparing healthy cells.
- No human clinical trials completed as of 2025.
- Preclinical studies showed improved fitness, fur density, and organ function in aged mice.
Community Insights
Summarised from 4 sourcesFOXO4-DRI is an innovative senolytic peptide designed to selectively target and eliminate senescent 'zombie' cells. As a D-retro-inverso analog of the FOXO4 protein segment, it disrupts the FOXO4-p53 interaction in senescent cells, freeing p53 to trigger apoptosis and clear dysfunctional cells. Inte
Common Dosages Reported
- 300-500mcg Daily during dosing weeks
- Standard protocol dosing
Side Effects Mentioned
- Generally mild, individual variation expected
- See full guide for detailed safety info
Stacking Suggestions
- Consult research and healthcare provider before stacking
What people are saying
Results vary based on individual response
Consistent dosing and timing important
Reviews & Discussion
Real experiences shared by the community — not medical advice.
No Measurable Anti-Aging Benefits
A user reported no visible anti-aging effects or changes in biomarkers after a full course of FOXO4-DRI. They concluded that the high cost of the peptide did not justify the lack of measurable results in their specific case.
Subjective Energy and Sleep Improvement
One individual described an 'energy surge' and improved sleep quality while taking Proxofim. However, they expressed uncertainty about whether these effects were due to the peptide or a placebo, leading them to suggest more rigorous tracking.
Joint Pain and Inflammation Concerns
A forum member experienced significant joint pain and overall body aches shortly after initiating a FOXO4-DRI cycle. They discontinued the trial due to concerns that the peptide might be inducing widespread inflammation or an immune response.
FOXO4-DRI Effects on Hair and Stamina
A user reported a mild to moderate decrease in hair loss and a slight increase in stamina after using FOXO4-DRI. They noted that the effects were subtle but perceptible, particularly regarding physical endurance during exercise.
Positive results with IV administration but pain with sub-q
A user reported excellent results after performing a protocol of 20mg IV infusions twice weekly for 45 days. They noted that subcutaneous administration was extremely painful and resulted in wasted product, recommending the intravenous route instead.
No discussion yet — be the first.
No notes yet — be the first.